Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Clinical and Experimental Rheumatology|February 5, 2016
A polyarticular onset and diabetes could be the main predictors of cardiovascular events in psoriatic arthritisPatricia Tejón, Isla Morante, Iván Cabezas, et al.Clinical Rheumatology|February 23, 2018
Prevalence and type II diabetes-associated factors in psoriatic arthritisRubén Queiro, Andrés Lorenzo, Estefanía Pardo, et al.The Australasian Journal of Dermatology|February 22, 2011
Psoriasis induced by cetuximab: a paradoxical adverse effectAlbert Mas-Vidal, Pablo Coto-Segura, Cristina Galache-Osuna, et al.Joint Bone Spine|January 12, 2016
Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritisSara Alonso, Patricia Tejón, Cristina Sarasqueta, et al.International Journal of Rheumatic Diseases|November 7, 2018
Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritisRubén Queiro, Andrés Lorenzo, Patricia Tejón, et al.Molecular Diagnosis & Therapy|July 4, 2019
NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript AnalysisPablo Coto-Segura, Leire González-Lara, Ana Batalla, et al.Dermatology (Basel, Switzerland)|January 31, 2015
Psoriasis vulgaris with or without arthritis and independent of disease severity or duration is a risk factor for hypercholesterolemiaJorge Santos-Juanes, Pablo Coto-Segura, Ivan Fernández-Vega, et al.Actas Dermo-Sifiliograficas|June 27, 2006
[Cutaneous semiology: a historical perspective of the evolution of basic terminology in Spain]Francisco Vázquez-López, Pablo Coto, María L Gotor, et al.Journal of Dermatological Science|June 25, 2014
Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitusNoemí Eirís, Leire González-Lara, Jorge Santos-Juanes, et al.The Australasian Journal of Dermatology|February 8, 2012
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitorAlbert Mas-Vidal, Jorge Santos-Juanes, Altea Esteve-Martinez, et al.Pageof 7